LOX inhibitors (Institute of Cancer Research)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameLOX inhibitors (Institute of Cancer Research)
Drug Alias Namelysyl oxidase inhibitors (Institute of Cancer Research)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysyl oxidase inhibitors
TargetsLysyl oxidase
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A